{{Rsnum
|rsid=3781835
|Gene=SORL1
|Chromosome=11
|position=121577545
|Orientation=plus
|GMAF=0.04683
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SORL1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 4.5 | 95.5
| HCB | 0.0 | 8.0 | 92.0
| JPT | 1.8 | 29.5 | 68.8
| YRI | 0.0 | 9.5 | 90.5
| ASW | 1.8 | 14.0 | 84.2
| CHB | 0.0 | 8.0 | 92.0
| CHD | 0.9 | 10.1 | 89.0
| GIH | 0.0 | 5.0 | 95.0
| LWK | 0.0 | 19.3 | 80.7
| MEX | 0.0 | 6.9 | 93.1
| MKK | 0.6 | 14.1 | 85.3
| TSI | 1.0 | 2.9 | 96.1
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3781835
|Name_s=
|Gene_s=SORL1
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363860
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3781835
|overall_frequency_n=8
|overall_frequency_d=128
|overall_frequency=0.0625
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=8
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}